| 000 | 01651 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516003201.0 | ||
| 264 | 0 | _c20110802 | |
| 008 | 201108s 0 0 eng d | ||
| 022 | _a1573-2592 | ||
| 024 | 7 |
_a10.1007/s10875-010-9466-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBarros, Priscila O | |
| 245 | 0 | 0 |
_aSubstance P enhances Th17 phenotype in individuals with generalized anxiety disorder: an event resistant to glucocorticoid inhibition. _h[electronic resource] |
| 260 |
_bJournal of clinical immunology _cFeb 2011 |
||
| 300 |
_a51-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnxiety Disorders _xdrug therapy |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aDrug Resistance |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlucocorticoids _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLymphocyte Activation _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 |
_aSubstance P _ximmunology |
| 650 | 0 | 4 |
_aT-Lymphocytes _xdrug effects |
| 650 | 0 | 4 |
_aTh17 Cells _xdrug effects |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aFerreira, Thais B | |
| 700 | 1 | _aVieira, Morgana M M | |
| 700 | 1 | _aAlmeida, Carla Renata M | |
| 700 | 1 | _aAraújo-Lima, Carlos Fernando | |
| 700 | 1 | _aSilva-Filho, Renato G | |
| 700 | 1 | _aHygino, Joana | |
| 700 | 1 | _aAndrade, Regis M | |
| 700 | 1 | _aAndrade, Arnaldo F | |
| 700 | 1 | _aBento, Cleonice A | |
| 773 | 0 |
_tJournal of clinical immunology _gvol. 31 _gno. 1 _gp. 51-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s10875-010-9466-6 _zAvailable from publisher's website |
| 999 |
_c20195136 _d20195136 |
||